Approval · Notice of Compliance 21542 · 2018
BARACLUDE: Notice of Compliance 21542
Issued November 21, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21542
- Date
- November 21, 2018
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to Product Monograph to remove the oral suspension presentation (0.05mg/ml).
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BARACLUDE | Not yet assigned | — |
Medicinal ingredients
- ENTECAVIR 0.5 MG per TAB